Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Effects of procalcitonin testing on antibiotic use and clinical outcomes in patients with upper respiratory tract infections. An individual patient data meta-analysis.

Odermatt J, Friedli N, Kutz A, Briel M, Bucher HC, Christ-Crain M, Burkhardt O, Welte T, Mueller B, Schuetz P.

Clin Chem Lab Med. 2017 Jun 29. pii: /j/cclm.ahead-of-print/cclm-2017-0252/cclm-2017-0252.xml. doi: 10.1515/cclm-2017-0252. [Epub ahead of print]

2.

Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis.

Mathioudakis AG, Chatzimavridou-Grigoriadou V, Corlateanu A, Vestbo J.

Eur Respir Rev. 2017 Jan 31;26(143). pii: 160073. doi: 10.1183/16000617.0073-2016. Print 2017 Jan. Review.

3.

Procalcitonin-guided diagnosis and antibiotic stewardship revisited.

Sager R, Kutz A, Mueller B, Schuetz P.

BMC Med. 2017 Jan 24;15(1):15. doi: 10.1186/s12916-017-0795-7. Review.

4.

Tools for outcome prediction in patients with community acquired pneumonia.

Khan F, Owens MB, Restrepo M, Povoa P, Martin-Loeches I.

Expert Rev Clin Pharmacol. 2017 Feb;10(2):201-211. doi: 10.1080/17512433.2017.1268051. Epub 2016 Dec 12. Review.

PMID:
27911103
5.

Predicting In-Hospital Treatment Failure (≤ 7 days) in Patients with COPD Exacerbation Using Antibiotics and Systemic Steroids.

Crisafulli E, Torres A, Huerta A, Guerrero M, Gabarrús A, Gimeno A, Martinez R, Soler N, Fernández L, Wedzicha JA, Menéndez R.

COPD. 2016;13(1):82-92. doi: 10.3109/15412555.2015.1057276. Epub 2015 Oct 9.

PMID:
26451913
6.

Biomarker-guided personalised emergency medicine for all - hope for another hype?

Schuetz P, Aujesky D, Müller C, Müller B.

Swiss Med Wkly. 2015 Feb 19;145:w14079. doi: 10.4414/smw.2015.14079. eCollection 2015. Review.

7.

[Diagnostic value of serum procalcitonin in identifying the etiology of non-responding community-acquired pneumonia after initial antibiotic therapy].

Wang Z, Zhang X, Wu J, Zhang W, Kuang H, Li X, Xuan W, Wang K, Ma L.

Zhonghua Jie He He Hu Xi Za Zhi. 2014 Nov;37(11):824-30. Chinese.

PMID:
25604112
8.

[Comparison of 3-hour and 30-minute infusion regimens for meropenem in patients with hospital acquired pneumonia in intensive care unit: a randomized controlled clinical trial].

Wang Z, Shan T, Liu Y, Ding S, Li C, Zhai Q, Chen X, Du B, Li Y, Zhang J, Wang H, Wu D.

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014 Sep;26(9):644-9. doi: 10.3760/cma.j.issn.2095-4352.2014.09.008. Chinese.

9.

Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trial.

Schuetz P, Kutz A, Grolimund E, Haubitz S, Demann D, Vögeli A, Hitz F, Christ-Crain M, Thomann R, Falconnier C, Hoess C, Henzen C, Marlowe RJ, Zimmerli W, Mueller B; ProHOSP Study Group.

Int J Cardiol. 2014 Aug 20;175(3):464-72. doi: 10.1016/j.ijcard.2014.06.022. Epub 2014 Jun 27.

PMID:
25005339
10.

Community-acquired pneumonia: judicious use of antibiotics or treatment failure?

Behere S, Garber MD.

Hosp Pediatr. 2013 Apr;3(2):180-1. No abstract available.

11.

Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.

Schuetz P, Müller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bhatnagar N, Bucher HC, Briel M.

Evid Based Child Health. 2013 Jul;8(4):1297-371. doi: 10.1002/ebch.1927. Review.

PMID:
23877944
12.

Clinical outcomes associated with procalcitonin algorithms to guide antibiotic therapy in respiratory tract infections.

Schuetz P, Briel M, Mueller B.

JAMA. 2013 Feb 20;309(7):717-8. doi: 10.1001/jama.2013.697.

PMID:
23423417
13.

Efficacy and Safety of Procalcitonin-Guided Antibiotic Therapy in Lower Respiratory Tract Infections.

Drozdov D, Dusemund F, Müller B, Albrich WC.

Antibiotics (Basel). 2013 Jan 22;2(1):1-10. doi: 10.3390/antibiotics2010001.

14.

Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.

Schuetz P, Müller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bhatnagar N, Bucher HC, Briel M.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD007498. doi: 10.1002/14651858.CD007498.pub2. Review.

PMID:
22972110
15.

Biomarkers and community-acquired pneumonia: tailoring management with biological data.

Torres A, Ramirez P, Montull B, Menéndez R.

Semin Respir Crit Care Med. 2012 Jun;33(3):266-71. doi: 10.1055/s-0032-1315638. Epub 2012 Jun 20. Review.

PMID:
22718212
16.

Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis.

Schuetz P, Briel M, Christ-Crain M, Stolz D, Bouadma L, Wolff M, Luyt CE, Chastre J, Tubach F, Kristoffersen KB, Wei L, Burkhardt O, Welte T, Schroeder S, Nobre V, Tamm M, Bhatnagar N, Bucher HC, Mueller B.

Clin Infect Dis. 2012 Sep;55(5):651-62. doi: 10.1093/cid/cis464. Epub 2012 May 9.

17.

Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD.

Soler N, Esperatti M, Ewig S, Huerta A, Agustí C, Torres A.

Eur Respir J. 2012 Dec;40(6):1344-53. doi: 10.1183/09031936.00150211. Epub 2012 Apr 20.

18.

Surrogate markers and microbiologic end points.

Wunderink RG.

Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S126-30. doi: 10.1086/653061. Review.

PMID:
20597662
19.

[Respiratory infections research: a perspective from the tuberculosis and respiratory infections area (TIR)].

Jesús Cremades M, Luiza de Souza-Galvão M, García JM, Menéndez R.

Arch Bronconeumol. 2009;45 Suppl 1:11-5. doi: 10.1016/S0300-2896(09)70265-0. Review. Spanish.

20.

[Should antibiotics be used for acute rhinosinusitis? The argument is not yet settled].

Damoiseaux RA.

Ned Tijdschr Geneeskd. 2008 Oct 25;152(43):2319-21. Dutch.

PMID:
19024060

Supplemental Content

Loading ...
Support Center